ISSUE 92 I MARCH 2020

the path of 

yeast resistance 

The need for more anti-fungal medications is high, but developing new solutions comes with serious challenges

Packaging: turning the industry green

Leaks and fraud in global pharma

Resolving the US opioid crisis

In association with

Packaging: turning the industry green

Leaks and fraud in global pharma

Resolving the US opioid crisis

02/24/2024 14:36:51
  • Home | The path of yeast resistance
  • NSF
  • Editorial
  • Contents
  • News
  • Emirates SkyCargo
  • The pharma industry briefing
  • A resolution for the new decade: resolve the US opioid crisis
  • Eurofins CDMO
  • Precision medicine: what barriers remain?
  • Can recyclable packaging turn the pharma industry green?
  • Phoenix Company Insight
  • Phoenix
  • Vertex’s Trikafta: treating the genetic basis of cystic fibrosis
  • Accurate Biometrics Company Insight
  • Accurate Biometrics
  • Q&A: talking innovation with the Association for the Cannabinoid Industry
  • Yeast of burden: how to develop better antifungal drugs
  • Loose lips bring risks: protecting pharma against leaks and fraud
  • Why are patients struggling to access life-saving immune globulin?
  • Mimotopes
  • Deals in brief powered by GlobalData
  • Nolato Company Insight
  • Nolato
  • The key list powered by GlobalData
  • Events
  • Next issue
02/21/2020 00:00:00